Abstract
A 32-year-old man in Japan experienced respiratory failure after receiving the first dose of coronavirus disease (COVID-19) vaccine. He was treated with noninvasive ventilation and corticosteroids. Serologic test results suggested previous COVID-19; therefore, he received a diagnosis of multisystem inflammatory syndrome. COVID-19 vaccination could be a trigger for this condition.
Keywords: COVID-19; Japan; MIS-A; SARS-CoV-2; anti-nucleocapsid antibody; anti-spike antibody; coronavirus disease; cytokine profile; hyperinflammatory state; multisystem inflammatory syndrome; myocardial injury; respiratory failure; severe acute respiratory syndrome coronavirus 2; vaccination.
All Keywords
【저자키워드】 COVID-19, coronavirus disease, severe acute respiratory syndrome coronavirus 2, SARS-CoV-2, Respiratory failure, vaccination., Multisystem inflammatory syndrome, myocardial injury, Japan, cytokine profile, MIS-A, anti-spike antibody, anti-nucleocapsid antibody, hyperinflammatory state, 【초록키워드】 coronavirus disease, Vaccine, coronavirus, Corticosteroids, vaccination, Respiratory failure, Diagnosis, Noninvasive ventilation, cytokine, severe acute respiratory syndrome Coronavirus, myocardial injury, COVID-19 vaccination, Japan, cytokine profile, Anti-spike, anti-spike antibody, hyperinflammatory state, Inflammatory, Trigger, serologic test, acute respiratory syndrome, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, first dose, syndrome, Hyperinflammatory, Myocardial, receiving, treated, suggested, 【제목키워드】 mRNA,
【저자키워드】 COVID-19, coronavirus disease, severe acute respiratory syndrome coronavirus 2, SARS-CoV-2, Respiratory failure, vaccination., Multisystem inflammatory syndrome, myocardial injury, Japan, cytokine profile, MIS-A, anti-spike antibody, anti-nucleocapsid antibody, hyperinflammatory state, 【초록키워드】 coronavirus disease, Vaccine, coronavirus, Corticosteroids, vaccination, Respiratory failure, Diagnosis, Noninvasive ventilation, cytokine, severe acute respiratory syndrome Coronavirus, myocardial injury, COVID-19 vaccination, Japan, cytokine profile, Anti-spike, anti-spike antibody, hyperinflammatory state, Inflammatory, Trigger, serologic test, acute respiratory syndrome, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, first dose, syndrome, Hyperinflammatory, Myocardial, receiving, treated, suggested, 【제목키워드】 mRNA,
{{{ 추상적인 }}}
일본에서 32세 남성이 코로나19(COVID-19) 백신 1차 접종 후 호흡부전을 경험했습니다. 그는 비침습적 인공호흡과 코르티코스테로이드로 치료를 받았습니다. 혈청학적 검사 결과는 이전 COVID-19를 시사합니다. 따라서 그는 다기관 염증 증후군 진단을 받았습니다. COVID-19 예방 접종은 이 상태의 방아쇠가 될 수 있습니다.
{{ 키워드: }} 코로나19; 일본; 미스-A; 사스 코로나바이러스 2; 항-뉴클레오캡시드 항체; 스파이크 방지 항체; 코로나바이러스 질환; 사이토카인 프로필; 과염증 상태; 다기관 염증 증후군; 심근 손상; 호흡 부전; 중증 급성 호흡기 증후군 코로나바이러스 2; 백신 접종.